Comparison of ACCP and AAOS guidelines for VTE prophylaxis after total hip and total knee arthroplasty

Area of Science:

• Orthopedic Surgery
• Cardiovascular Medicine
• Pharmacology

Background:

• Orthopedic surgeons express reservations about the American College of Chest Physicians (ACCP) thromboprophylaxis guidelines for total hip (THA) and total knee arthroplasty (TKA).
• Concerns include the ACCP's acceptance of venographically assessed asymptomatic deep venous thrombosis as a clinical endpoint.
• Potential underestimation of bleeding and wound complication risks in unselected patients is also noted.

Purpose of the Study:

• To review the clinical practice guidelines developed by the American Academy of Orthopaedic Surgeons (AAOS) for thromboprophylaxis in THA and TKA.
• To address concerns raised by orthopedists regarding existing ACCP guidelines.
• To highlight an approach focused on preventing symptomatic pulmonary embolism while minimizing pharmacologic prophylaxis-related bleeding.

Main Methods:

• Review of existing literature and clinical guidelines.
• Comparative analysis of ACCP and AAOS guideline recommendations.
• Discussion of clinical trial endpoints and risk assessment in orthopedic surgery patients.

Main Results:

• Symptomatic pulmonary embolism is a rare complication following THA and TKA.
• The AAOS has developed specific guidelines to address this complication.
• The AAOS guidelines prioritize preventing major bleeding and wound complications.

Conclusions:

• Orthopedic surgeons have specific practice concerns regarding ACCP thromboprophylaxis guidelines for THA/TKA.
• The AAOS guidelines offer a tailored approach focusing on preventing symptomatic pulmonary embolism.
• Minimizing bleeding risk through pharmacologic prophylaxis is a key consideration in the AAOS guidelines.